Structure-activity relationship study of newly synthesized iridium-iii complexes as potential series for treating thrombotic diseases

HIGHLIGHTS

• who: Chih-Hao Yang and collaborators from the Department of Pharmacology, Schools of Medicine, College of Medicine, Taipei Medical University, No250, Taipei, Taiwan have published the paper: Structure-Activity Relationship Study of Newly Synthesized Iridium-III Complexes as Potential Series for Treating Thrombotic Diseases, in the Journal: (JOURNAL) of 20/01/2017
• what: The authors evaluated the in vitro antiplatelet in vivo antithrombotic and structure-activity relationship (SAR) of newly Ir Ir-1 Ir-2 and Ir-4 in agonists-induced human platelets. The authors report the synthesis, in_vitro antiplatelet, in_vivo antithrombotic, and cytotoxicity properties . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.